Colgate-Palmolive Q1 sales beat estimates on broad-based growth
Colgate-Palmolive Company CL | 0.00 |
Overview
Consumer products maker's Q1 net sales rose 8.4%, beating analyst expectations
Adjusted EPS for Q1 grew 7% and beat analyst expectations
Company expanded Strategic Growth and Productivity Program, raising projected charges and savings
Outlook
Colgate-Palmolive maintains 2026 net sales growth guidance of 2% to 6%
Company now expects 2026 gross profit margin to be down, versus up previously
Colgate-Palmolive expects volatile macroeconomic conditions and slower category growth to continue in 2026
Result Drivers
BROAD-BASED SALES GROWTH - Co said net and organic sales grew in every category and in four of five divisions, with both pricing and volume contributing
PRIVATE LABEL PET FOOD EXIT - Organic sales growth was negatively affected by lower private label pet food sales
HIGHER ADVERTISING SPENDING - Advertising spending increased year over year
Company press release: ID:nBw1SbSpda
Key Details
Metric |
Beat/Miss |
Actual |
Consensus Estimate |
Q1 Sales |
Beat |
$5.32 bln |
$5.22 bln (12 Analysts) |
Q1 Adjusted EPS |
Beat |
$0.97 |
$0.95 (16 Analysts) |
Q1 EPS |
|
$0.80 |
|
Analyst Coverage
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 13 "strong buy" or "buy", 8 "hold" and 1 "sell" or "strong sell"
The average consensus recommendation for the personal products peer group is "buy"
Wall Street's median 12-month price target for Colgate-Palmolive Co is $98.00, about 14.8% above its April 30 closing price of $85.36
The stock recently traded at 22 times the next 12-month earnings vs. a P/E of 23 three months ago
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.
